Juichi Tanabe

562 total citations
25 papers, 417 citations indexed

About

Juichi Tanabe is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Juichi Tanabe has authored 25 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in Juichi Tanabe's work include Platelet Disorders and Treatments (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (3 papers). Juichi Tanabe is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (3 papers). Juichi Tanabe collaborates with scholars based in Japan. Juichi Tanabe's co-authors include Hiroshi Mohri, Takao Okubo, Atsuo Maruta, Heiwa Kanamori, S Motomura, Michio Matsuzaki, Yoshiaki Ishigatsubo, Hiroyuki Fujita, Rika Sakai and Shin Fujisawa and has published in prestigious journals such as Journal of Biological Chemistry, British Journal of Haematology and American Journal of Clinical Pathology.

In The Last Decade

Juichi Tanabe

24 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juichi Tanabe Japan 12 235 74 70 62 57 25 417
B. Dörken Germany 7 108 0.5× 65 0.9× 86 1.2× 98 1.6× 38 0.7× 22 384
Aude Marie‐Cardine France 9 137 0.6× 44 0.6× 50 0.7× 73 1.2× 34 0.6× 24 414
G. А. Novichkova Russia 11 238 1.0× 89 1.2× 44 0.6× 87 1.4× 44 0.8× 147 457
Clauvel Jp France 8 152 0.6× 42 0.6× 41 0.6× 34 0.5× 32 0.6× 28 358
Philippe Genet France 10 203 0.9× 95 1.3× 118 1.7× 247 4.0× 46 0.8× 44 536
I. Yaniv Israel 14 125 0.5× 74 1.0× 21 0.3× 48 0.8× 63 1.1× 29 471
Zafer Başlar Türkiye 13 307 1.3× 182 2.5× 119 1.7× 120 1.9× 56 1.0× 82 578
Tomiko Ryu Japan 8 162 0.7× 37 0.5× 27 0.4× 54 0.9× 63 1.1× 27 323
Jesse Keller United States 10 232 1.0× 81 1.1× 28 0.4× 193 3.1× 67 1.2× 21 476
Paul I. Liu United States 7 245 1.0× 75 1.0× 35 0.5× 75 1.2× 49 0.9× 12 421

Countries citing papers authored by Juichi Tanabe

Since Specialization
Citations

This map shows the geographic impact of Juichi Tanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juichi Tanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juichi Tanabe more than expected).

Fields of papers citing papers by Juichi Tanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juichi Tanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juichi Tanabe. The network helps show where Juichi Tanabe may publish in the future.

Co-authorship network of co-authors of Juichi Tanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Juichi Tanabe. A scholar is included among the top collaborators of Juichi Tanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juichi Tanabe. Juichi Tanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Maruta, A, Minoru Yoshida, Rika Sakai, et al.. (2001). Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplantation. 27(3). 307–310. 72 indexed citations
4.
Ohashi, Kazuteru, Juichi Tanabe, Reiko Watanabe, et al.. (2000). The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno‐occlusive disease after stem cell transplantation. American Journal of Hematology. 64(1). 32–38. 4 indexed citations
5.
Tomita, Naoto, Fumio Kodama, Rika Sakai, et al.. (2000). Predictive Factors for Central Nervous System Involvement in Non-Hodgkin's Lymphoma: Significance of Very High Serum LDH Concentrations. Leukemia & lymphoma. 38(3-4). 335–343. 45 indexed citations
6.
Ohashi, Kazuteru, Juichi Tanabe, Reiko Watanabe, et al.. (2000). The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. American Journal of Hematology. 64(1). 32–38. 98 indexed citations
7.
Tomita, Naoto, Heiwa Kanamori, Juichi Tanabe, et al.. (2000). [Treatment outcome in elderly patients with aggressive non-Hodgkin's lymphoma].. PubMed. 41(7). 568–75. 1 indexed citations
8.
Fujisawa, Shin, Juichi Tanabe, Hiroshi Harano, et al.. (1999). Acute Minimally Differentiated Myeloid Leukemia (M0) with Inv(3)(q21q26). Leukemia & lymphoma. 35(5-6). 627–630. 4 indexed citations
9.
Fujisawa, Shin, Shigeki Motomura, Katsumichi Fujimaki, et al.. (1999). Primary Esophageal T Cell Lymphoma. Leukemia & lymphoma. 33(1-2). 199–202. 2 indexed citations
10.
Maruta, A, Juichi Tanabe, Heiwa Kanamori, et al.. (1999). Long-term liver function of recipients with hepatitis G virus infection after bone marrow transplantation. Bone Marrow Transplantation. 24(4). 359–363. 3 indexed citations
11.
Mohri, Hiroshi, Juichi Tanabe, Eriko Yamazaki, et al.. (1996). Acquired type 2A von Willebrand disease in chronic myelocytic leukemia.. PubMed. 10(3). 123–33. 21 indexed citations
12.
Mohri, Hiroshi, et al.. (1996). Identification of a Novel Binding Site to the Integrin αIIbβ3 Located in the C-terminal Heparin-binding Domain of Human Plasma Fibronectin. Journal of Biological Chemistry. 271(26). 15724–15728. 18 indexed citations
13.
14.
Mohri, Hiroshi, Hiroyuki Fujita, Y. Asakura, et al.. (1995). Inhalation Therapy of Paromomycin Is Effective for Respiratory Infection and Hypoxia by Cryptosporidium With AIDS. The American Journal of the Medical Sciences. 309(1). 60–62. 11 indexed citations
15.
Mohri, Hiroshi, Juichi Tanabe, Motoyuki Yoshida, et al.. (1995). Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factor. Blood Coagulation & Fibrinolysis. 6(6). 561–566. 36 indexed citations
16.
Hashimoto, Yoshimi, Juichi Tanabe, Hiroshi Mohri, & Takao Ohkubo. (1994). Autoimmune Antibody in a Patient with Idiopathic Thrombocytopenic Purpura Reacted to the Platelet Low Molecular Weight Glycoproteins and Activated Platelets. American Journal of Clinical Pathology. 101(3). 370–374. 5 indexed citations
17.
Tamura, Toshihide, Heiwa Kanamori, Mikio Ohtsuka, et al.. (1994). Cold agglutinin disease following allogeneic bone marrow transplantation.. PubMed. 13(3). 321–3. 13 indexed citations
18.
Mohri, Hiroshi, Juichi Tanabe, Hiroyuki Fujita, Heiwa Kanamori, & Takao Ohkubo. (1993). Anti‐fibrinogen antibody mediates fibrinogen binding to platelet membrane glycoprotein IIb‐IIIa. British Journal of Haematology. 85(2). 341–347. 2 indexed citations
19.
Tanabe, Juichi, et al.. (1992). [Myelodysplastic syndrome associated with marked eosinophilia and basophilia].. PubMed. 33(2). 189–93. 3 indexed citations
20.
Sasaki, Shin, Heiwa Kanamori, Rie Okamoto, et al.. (1992). Effect of leukocyte romoval filter on platelet function and prevention of post-transfusion side reactions.. Journal of the Japan Society of Blood Transfusion. 38(1). 3–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026